BioRegenMed

A leader of novel biomedical materials for tissue wound repair

Headquarters
Changzhou
Business Model
B2B

About

BioRegen Biomedical (Changzhou) Co., Ltd. is a Chinese high-tech company specializing in the research, development, production, and sales of novel biomedical materials for tissue wound repair and drug sustained-release applications. The company develops functional repair and regeneration products across gynecology (GYN) and ear, nose, and throat (ENT) clinical segments, with CE-approved products such as PureRegen Gel Sinus for post-nasal endoscopic surgery wound care. BioRegen holds ISO 14001 environmental management and ISO 45001 occupational health and safety certifications, underscoring its commitment to quality manufacturing standards. The company aims to become a global leader in novel biomedical materials that rejuvenate injured tissue.

Summary

BioRegenMed is a Biotech company based in Changzhou, China.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioRegenMed on Indexed.vc
<a href="https://indexed.vc/companies/bioregenmed"><img src="https://indexed.vc/api/badge/company/bioregenmed" alt="BioRegenMed on Indexed.vc" width="260" height="76" /></a>